Five notes about the company’s second quarter performance:
1. Net sales were $2 billion, up 60.7 percent.
2. Spine and dental sales were $263.5 million, up 73.1 percent from the same time last year.
3. Knee sales were up 77.5 percent at $665.6 million net sales. Hip sales also increased 44 percent globally with $474.6 million net sales.
4. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales were up 57.9 percent at $462.1 million.
5. The company updated its projected ranges for revenue growth and expects to see a 14.5 percent to 16.5 percent increase by the end of the year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
